Organogenesis

Organogenesis company information, Employees & Contact Information

Explore related pages

Related company profiles:

Organogenesis™ is a leading regenerative medicine company focused on the development, manufacture, and commercialization of solutions for the advanced wound care and surgical and sports medicine markets. Organogenesis offers a comprehensive portfolio of innovative regenerative products to address patient needs across the continuum of care.

Company Details

Employees
967
Founded
-
Address
150 Dan Road, Canton,massachusetts 02021,united States
Phone
117815750775
Email
al****@****ano.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Canton, Massachusetts
Looking for a particular Organogenesis employee's phone or email?

Organogenesis Questions

News

Organogenesis Provides Update on Second Phase 3 ReNu® Study - Ortho Spine News

Organogenesis Provides Update on Second Phase 3 ReNu® Study Ortho Spine News

Organogenesis Holdings Inc. Announced Results from Second Phase 3 Trial of ReNu for Knee Osteoarthritis Pain Management - Quiver Quantitative

Organogenesis Holdings Inc. Announced Results from Second Phase 3 Trial of ReNu for Knee Osteoarthritis Pain Management Quiver Quantitative

6.9-Point Pain Reduction: Organogenesis ReNu Shows Promise in Knee Osteoarthritis Despite Missing P-Value - Stock Titan

6.9-Point Pain Reduction: Organogenesis ReNu Shows Promise in Knee Osteoarthritis Despite Missing P-Value Stock Titan

Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025 - The Manila Times

Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025 The Manila Times

Organogenesis Holdings Inc. Announces $130 Million Private - GlobeNewswire

Organogenesis Holdings Inc. Announces $130 Million Private GlobeNewswire

Organogenesis Names New Chief Commercial Officer and Chief Operating Officer - PR Newswire

Organogenesis Names New Chief Commercial Officer and Chief Operating Officer PR Newswire

Organogenesis Holdings Inc. Expands Manufacturing Capacity with New Facility in Smithfield, Rhode Island - Quiver Quantitative

Organogenesis Holdings Inc. Expands Manufacturing Capacity with New Facility in Smithfield, Rhode Island Quiver Quantitative

Organogenesis Appoints Prathyusha Duraibabu to Board of Directors - citybiz

Organogenesis Appoints Prathyusha Duraibabu to Board of Directors citybiz

Avista Healthcare Partners Invests in Organogenesis Holdings’ Series A Convertible Preferred Stock - Ropes & Gray LLP

Avista Healthcare Partners Invests in Organogenesis Holdings’ Series A Convertible Preferred Stock Ropes & Gray LLP

Organogenesis Receives FDA Clearance for Next Generation PuraPly Surgical Solution - Yahoo Finance

Organogenesis Receives FDA Clearance for Next Generation PuraPly Surgical Solution Yahoo Finance

Organogenesis signs Smithfield lease with subsidies in hand - The Business Journals

Organogenesis signs Smithfield lease with subsidies in hand The Business Journals

Advanced Medical Solutions Group and Organogenesis Inc. Enter into Patent Out-licensing Agreement - PR Newswire

Advanced Medical Solutions Group and Organogenesis Inc. Enter into Patent Out-licensing Agreement PR Newswire

Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance - Ortho Spine News

Organogenesis Holdings Inc. Reports Fourth Quarter 2023 and Fiscal Year 2023 Financial Results; Introduces Fiscal Year 2024 Guidance Ortho Spine News

Organogenesis Holdings Inc. Applauds CMS Decision on Coverage for Skin Substitute Products for Diabetic and Venous Ulcers - Quiver Quantitative

Organogenesis Holdings Inc. Applauds CMS Decision on Coverage for Skin Substitute Products for Diabetic and Venous Ulcers Quiver Quantitative

Organogenesis Appoints Michele Korfin and Gilberto Quintero, Ph.D. to Board of Directors - citybiz

Organogenesis Appoints Michele Korfin and Gilberto Quintero, Ph.D. to Board of Directors citybiz

Organogenesis Celebrates Launch of Advancing Healing Education Resource Center and Highlights Latest Wound Care Research at SAWC Fall 2018 - PR Newswire

Organogenesis Celebrates Launch of Advancing Healing Education Resource Center and Highlights Latest Wound Care Research at SAWC Fall 2018 PR Newswire

Organogenesis Holdings Inc. Receives Positive Nasdaq Listing Determination - PR Newswire

Organogenesis Holdings Inc. Receives Positive Nasdaq Listing Determination PR Newswire

Organogenesis Secures $30 Million in Financing to Fund Aggressive Expansion of Commercial Operations and Product Portfolio - PR Newswire

Organogenesis Secures $30 Million in Financing to Fund Aggressive Expansion of Commercial Operations and Product Portfolio PR Newswire

Organogenesis Holdings Inc. Announces New $100 Million Credit Agreement with Silicon Valley Bank and MidCap Financial - PR Newswire

Organogenesis Holdings Inc. Announces New $100 Million Credit Agreement with Silicon Valley Bank and MidCap Financial PR Newswire

Organogenesis Inc. Announces Acquisition of NuTech Medical - PR Newswire

Organogenesis Inc. Announces Acquisition of NuTech Medical PR Newswire

Former Siemens Executive Joins Organogenesis as Vice President of Human Resources - PR Newswire

Former Siemens Executive Joins Organogenesis as Vice President of Human Resources PR Newswire

ReNu Achieves Primary Endpoint in Phase 3 Trial for Knee Osteoarthritis - HCPLive

ReNu Achieves Primary Endpoint in Phase 3 Trial for Knee Osteoarthritis HCPLive

PuraPly™ and PuraPly Antimicrobial (AM)™ Receive Permanent Q-Code, Expanding Medicare Coverage After January 1 to Include Treatment in Private Physician Office Setting - PR Newswire

PuraPly™ and PuraPly Antimicrobial (AM)™ Receive Permanent Q-Code, Expanding Medicare Coverage After January 1 to Include Treatment in Private Physician Office Setting PR Newswire

Apligraf® is First Wound Healing Therapy to Demonstrate Significant Change in Chronic Wound's Genomic Profile - PR Newswire

Apligraf® is First Wound Healing Therapy to Demonstrate Significant Change in Chronic Wound's Genomic Profile PR Newswire

ORGO Stock Price and Chart — NASDAQ:ORGO - TradingView

ORGO Stock Price and Chart — NASDAQ:ORGO TradingView

Landmark New Data: Apligraf® Closes Significantly More Diabetic Foot Ulcers in Half the Time When Compared to Epifix - PR Newswire

Landmark New Data: Apligraf® Closes Significantly More Diabetic Foot Ulcers in Half the Time When Compared to Epifix PR Newswire

Wireless, skin-interfaced sensors for compression therapy - Science | AAAS

Wireless, skin-interfaced sensors for compression therapy Science | AAAS

Cutting-Edge Technology Brings Major Advance to Patients Lacking Healthy Gum Tissue - PR Newswire

Cutting-Edge Technology Brings Major Advance to Patients Lacking Healthy Gum Tissue PR Newswire

Organogenesis (ORGO) Stock Price, News & Analysis - MarketBeat

Organogenesis (ORGO) Stock Price, News & Analysis MarketBeat

Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference - Investing.com South Africa

Organogenesis Holdings Inc. to Participate in the BTIG Snowbird MedTech, Digital Health, Life Science and Diagnostic Tools Conference Investing.com South Africa

Top Organogenesis Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant